You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

systemic thromboembolic events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin

Completed
  • Venous Thromboembolism
  • +3 more
  • Rivaroxaban 20 MG [Xarelto]
  • +2 more
  • Metepec, Estado De Mexico, Mexico
    Instituto Mexicano Del Seguro Social
Aug 24, 2022

Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial

Withdrawn
  • Cerebral Stroke
  • +2 more
    • (no location specified)
    Nov 14, 2021

    Solid Carcinoma Trial (thrombogram)

    Not yet recruiting
    • Solid Carcinoma
    • thrombogram
    • (no location specified)
    Sep 20, 2023

    Identify and Describe Predictive Factors for Thromboembolic

    Not yet recruiting
    • Polycythemia Vera
    • Hydroxyurea
    • Ruxolitinib
    • (no location specified)
    Nov 2, 2022

    COVID-19, Thrombosis Embolism, Bleeding Trial in Stockholm (Dexamethasone)

    Completed
    • COVID-19
    • +2 more
    • Stockholm, Stockholms Län, Sweden
      Södersjukhuset
    Jun 24, 2022

    IBD, Thromboembolism, Coagulation Disorder Trial in Viseu (No intervention was made)

    Completed
    • Inflammatory Bowel Diseases
    • +2 more
    • No intervention was made
    • Viseu, Portugal
      Centro Hospitalar Tondela Viseu
    Dec 4, 2021

    Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

    Recruiting
    • Ulcerative Colitis
    • Thromboembolism
    • Madrid, Spain
      Hospital Universitario de La Princesa
    Aug 2, 2022

    Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)

    Recruiting
    • Deep-Venous Thrombosis
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Centre
    Apr 6, 2022

    Gastrointestinal Tumors, Thromboembolic Event Trial in Tunis (Enoxaparin 4000 IU)

    Completed
    • Gastrointestinal Neoplasms
    • Thromboembolic Event
    • Enoxaparin 4000 IU
    • Tunis, Tunis BAB Souika, Tunisia
      Charles Nicolle Hospital
    Jul 27, 2021

    Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Tucson (Catheter directed

    Recruiting
    • Pulmonary Embolism
    • +2 more
    • Catheter directed therapy
    • Systemic anticoagulation
    • Tucson, Arizona
      Banner University Medical Center
    Sep 21, 2022

    Vitiligo Trial (Upadacitinib, Placebo)

    Not yet recruiting
    • Vitiligo
    • (no location specified)
    Nov 1, 2023

    Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

    Not yet recruiting
    • Juvenile Idiopathic Arthritis
    • (no location specified)
    Nov 7, 2022

    Cardiac Implantable Electronic Devices on the Hemostatic System

    Recruiting
    • Thromboembolism
    • +2 more
    • Cardiac implantable electronic device implantation.
    • +4 more
    • Ryazan', Ryazan, Russian Federation
      Ryazan State Medical University
    Oct 26, 2022

    (Called RETAF-PS) UsingPatient Survey to Learn More About

    Not yet recruiting
    • Prevention of Thromboembolic Events
    • Atrial Fibrillation
    • Whippany, New Jersey
      Bayer
    Jul 21, 2022

    Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))

    Recruiting
    • Prevention of Thromboembolic Events
    • +4 more
    • Asundexian (BAY2433334)
    • Kiel, Schleswig-Holstein, Germany
      CRS-Kiel
    Jan 17, 2023

    United Sates That Looks at Safety and Effectiveness of Pradaxa

    Not yet recruiting
    • Venous Thromboembolism
      • (no location specified)
      Aug 1, 2023

      Hepatocellular Carcinoma(HCC) After Systemic Treatments

      Enrolling by invitation
      • Liver Cancer
      • +4 more
      • questionnaire survey
      • Wenzhou, Zhejiang, China
        Gang Chen
      Jul 1, 2022

      Investigate if Early Atrial Fibrillation Diagnosis Reduces Risk

      Recruiting
      • Atrial Fibrillation
      • Heart healthy Engagement Program with the Apple Watch Series 5 or later
      • Anti-Coagulation Adherence Module with the Apple Watch Series 5 or later
      • San Mateo, California
        Evidation Health
      Mar 4, 2022

      Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)

      Active, not recruiting
      • Antithrombin III Deficiency
      • Plasma-derived AT-III concentrate
      • (no location specified)
      May 5, 2022

      Thromboembolic Events in Patients Receiving Kcentra® or Plasma

      Completed
      • Hemorrhage
      • Kcentra®
      • Plasma
      • Oakland, California
        Study Site
      May 24, 2021

      Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • (no location specified)
      Oct 26, 2023

      Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary

      Active, not recruiting
      • Non-Small Cell Lung Cancer
        • Aurora, Colorado
        • +4 more
        Jan 21, 2022

        Pathways to Mitigate Immune-Related Adverse Events With Cancer

        Recruiting
        • Cancer
        • systemic corticosteroid or biologic
        • Denver, Colorado
        • +1 more
        Sep 8, 2021

        Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack Trial in Korea, Republic of (Antiplatelet Drug, Warfarin)

        Not yet recruiting
        • Antiphospholipid Syndrome
        • +5 more
        • Anyang, Korea, Republic of
        • +34 more
        Aug 15, 2023

        NETs in Solid Cancers Associated WithHigh Risk of Venous

        Unknown status
        • Pancreatic Cancer
        • +2 more
          • Boulogne-Billancourt, Haut De Seine, France
            Ambroise Pare Hospital
          Nov 6, 2020